{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["chemotherapy", "combination therapy", "lung cancer", "medicinal plants", "natural compounds", "phytochemicals", "preclinical models", "secondary metabolites", "synergistic interactions", "therapeutic strategies"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38794168", "DateRevised": {"Year": "2024", "Month": "05", "Day": "27"}, "Article": {"Language": ["eng"], "ELocationID": ["598", "10.3390/ph17050598"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "08"}], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "17", "Issue": "5", "PubDate": {"Year": "2024", "Month": "May", "Day": "08"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer.", "Abstract": {"AbstractText": ["In the current work, the synergy between natural compounds and conventional chemotherapeutic drugs is comprehensively reviewed in light of current preclinical research findings. The prognosis for lung cancer patients is poor, with a 5-year survival rate of 18.1%. The use of natural compounds in combination with conventional chemotherapeutic drugs has gained significant attention as a potential novel approach in the treatment of lung cancer. The present work highlights the importance of finding more effective therapies to increase survival rates. Chemotherapy is a primary treatment option for lung cancer but it has limitations such as reduced effectiveness because cancer cells become resistant. Natural compounds isolated from medicinal plants have shown promising anticancer or chemopreventive properties and their synergistic effect has been observed when combined with conventional therapies. The combined use of an anti-cancer drug and a natural compound exhibits synergistic effects, enhancing overall therapeutic actions against cancer cells. In conclusion, this work provides an overview of the latest preclinical research on medicinal plants and plant-derived compounds as alternative or complementary treatment options for lung cancer chemotherapy and discusses the potential of natural compounds in treating lung cancer with minimal side effects."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department II-Pharmaceutical Technology, Faculty of Pharmacy, \"Victor Babe\u015f\" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}], "LastName": "Bo\u021ba", "ForeName": "Mihaela", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department II-Pharmaceutical Technology, Faculty of Pharmacy, \"Victor Babe\u015f\" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}, {"Identifier": [], "Affiliation": "Formulation and Technology of Drugs Research Center, \"Victor Babe\u015f\" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}], "LastName": "Vlaia", "ForeName": "Lavinia", "Initials": "L"}, {"Identifier": ["0000-0002-3619-2484"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, \"Victor Babe\u015f\" University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}, {"Identifier": [], "Affiliation": "Research Centre for Pharmaco-Toxicological Evaluation, \"Victor Babe\u015f\" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}], "LastName": "J\u00eejie", "ForeName": "Alex-Robert", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, \"Victor Babe\u015f\" University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}, {"Identifier": [], "Affiliation": "Research Centre for Pharmaco-Toxicological Evaluation, \"Victor Babe\u015f\" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}], "LastName": "Marcovici", "ForeName": "Iasmina", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, \"Victor Babe\u015f\" University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}, {"Identifier": [], "Affiliation": "Research Centre for Pharmaco-Toxicological Evaluation, \"Victor Babe\u015f\" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}], "LastName": "Cri\u015fan", "ForeName": "Flavia", "Initials": "F"}, {"Identifier": ["0000-0003-2083-0581"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Discipline of Pneumology, Department of Infectious Diseases, \"Victor Babe\u0219\" University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}], "LastName": "Oancea", "ForeName": "Cristian", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, \"Victor Babe\u015f\" University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}, {"Identifier": [], "Affiliation": "Research Centre for Pharmaco-Toxicological Evaluation, \"Victor Babe\u015f\" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}], "LastName": "Dehelean", "ForeName": "Cristina Adriana", "Initials": "CA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Surgery, Clinical Hospital for Infectious Diseases and Pneumophthiology Dr. Victor Babes, 13 Gheorghe Adam Street, RO-300310 Timisoara, Romania."}], "LastName": "Mateescu", "ForeName": "Tudor", "Initials": "T"}, {"Identifier": ["0000-0002-2631-7028"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, \"Victor Babe\u015f\" University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}, {"Identifier": [], "Affiliation": "Research Centre for Pharmaco-Toxicological Evaluation, \"Victor Babe\u015f\" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania."}], "LastName": "Moac\u0103", "ForeName": "Elena-Alina", "Initials": "EA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Nasim F., Sabath B.F., Eapen G.A. Lung Cancer. Med. Clin. N. Am. 2019;103:463\u2013473. doi: 10.1016/j.mcna.2018.12.006.", "ArticleIdList": ["10.1016/j.mcna.2018.12.006", "30955514"]}, {"Citation": "Huang T.H., Wu T.H., Guo Y.H., Li T.L., Chan Y.L., Wu C.J. The Concurrent Treatment of Scutellaria baicalensis Georgi Enhances the Therapeutic Efficacy of Cisplatin but Also Attenuates Chemotherapy-Induced Cachexia and Acute Kidney Injury. J. Ethnopharmacol. 2019;243:112075. doi: 10.1016/j.jep.2019.112075.", "ArticleIdList": ["10.1016/j.jep.2019.112075", "31291609"]}, {"Citation": "Bade B.C., Dela Cruz C.S. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin. Chest Med. 2020;41:1\u201324. doi: 10.1016/j.ccm.2019.10.001.", "ArticleIdList": ["10.1016/j.ccm.2019.10.001", "32008623"]}, {"Citation": "Gahtori R., Tripathi A.H., Kumari A., Negi N., Paliwal A., Tripathi P., Joshi P., Rai R.C., Upadhyay S.K. Anticancer Plant-Derivatives: Deciphering Their Oncopreventive and Therapeutic Potential in Molecular Terms. Future J. Pharm. Sci. 2023;9:14. doi: 10.1186/s43094-023-00465-5.", "ArticleIdList": ["10.1186/s43094-023-00465-5"]}, {"Citation": "Kris M.G., Hellmann M.D., Chaft J.E. Chemotherapy for Lung Cancers: Here to Stay. Am. Soc. Clin. Oncol. Educ. Book. 2014;34:e375\u2013e380. doi: 10.14694/EdBook_AM.2014.34.e375.", "ArticleIdList": ["10.14694/EdBook_AM.2014.34.e375", "24857127"]}, {"Citation": "Monneret C. Impact Actuel Des Produits Naturels Sur La D\u00e9couverte de Nouveaux M\u00e9dicaments Anticanc\u00e9reux. Ann. Pharm. Fr. 2010;68:218\u2013232. doi: 10.1016/j.pharma.2010.04.004.", "ArticleIdList": ["10.1016/j.pharma.2010.04.004", "20637355"]}, {"Citation": "Alfonzetti T., Yasmin-Karim S., Ngwa W., Avery S. Phytoradiotherapy: An Integrative Approach to Cancer Treatment by Combining Radiotherapy With Phytomedicines. Front. Oncol. 2021;10:624663. doi: 10.3389/fonc.2020.624663.", "ArticleIdList": ["10.3389/fonc.2020.624663", "PMC7898963", "33628736"]}, {"Citation": "Mesas C., Segura B., Perazzoli G., Chico M.A., Moreno J., Doello K., Prados J., Melguizo C. Plant-Derived Bioactive Compounds for Rhabdomyosarcoma Therapy In Vitro: A Systematic Review. Appl. Sci. 2023;13:12964. doi: 10.3390/app132312964.", "ArticleIdList": ["10.3390/app132312964"]}, {"Citation": "Alfonzetti T., Moreau M., Yasmin-Karim S., Ngwa W., Avery S., Goia D. Phytoradiotherapy to Enhance Cancer Treatment Outcomes with Cannabidiol, Bitter Melon Juice, and Plant Hemoglobin. Front. Oncol. 2023;12:1085686. doi: 10.3389/fonc.2022.1085686.", "ArticleIdList": ["10.3389/fonc.2022.1085686", "PMC9909600", "36776362"]}, {"Citation": "Danciu C., Muntean D., Alexa E., Farcas C., Oprean C., Zupko I., Bor A., Minda D., Proks M., Buda V., et al. Phytochemical Characterization and Evaluation of the Antimicrobial, Antiproliferative, and Pro-Apoptotic Potential of Ephedra Alata Decne. Hydroalcoholic Extract against the MCF-7 Breast Cancer Cell Line. Molecules. 2019;24:13. doi: 10.3390/molecules24010013.", "ArticleIdList": ["10.3390/molecules24010013", "PMC6337526", "30577537"]}, {"Citation": "Cheon S.H., Kim K.S., Kim S., Jung H.S., Choi W.C., Eo W.K. Efficacy and Safety of Rhus Verniciflua Stokes Extracts in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer. Forsch. Komplementarmed. 2011;18:77\u201383. doi: 10.1159/000327306.", "ArticleIdList": ["10.1159/000327306", "21576976"]}, {"Citation": "Yu H.M., Liu Y.F., Cheng Y.F., Hu L.K., Hou M. Effects of Rhubarb Extract on Radiation Induced Lung Toxicity via Decreasing Transforming Growth Factor-Beta-1 and Interleukin-6 in Lung Cancer Patients Treated with Radiotherapy. Lung Cancer. 2008;59:219\u2013226. doi: 10.1016/j.lungcan.2007.08.007.", "ArticleIdList": ["10.1016/j.lungcan.2007.08.007", "17870203"]}, {"Citation": "Batbold U., Liu J.J. Artemisia santolinifolia-Mediated Chemosensitization via Activation of Distinct Cell Death Modes and Suppression of Stat3/Survivin-Signaling Pathways in Nsclc. Molecules. 2021;26:7200. doi: 10.3390/molecules26237200.", "ArticleIdList": ["10.3390/molecules26237200", "PMC8658962", "34885780"]}, {"Citation": "Wu J., Li Y., He Q., Yang X. Exploration of the Use of Natural Compounds in Combination with Chemotherapy Drugs for Tumor Treatment. Molecules. 2023;28:1022. doi: 10.3390/molecules28031022.", "ArticleIdList": ["10.3390/molecules28031022", "PMC9920618", "36770689"]}, {"Citation": "Mokhtari R.B., Homayouni T.S., Baluch N., Morgatskaya E., Kumar S., Das B., Yeger H. Combination Therapy in Combating Cancer. Oncotarget. 2017;8:38022\u201338043. doi: 10.18632/oncotarget.16723.", "ArticleIdList": ["10.18632/oncotarget.16723", "PMC5514969", "28410237"]}, {"Citation": "Park C.R., Lee J.S., Son C.G., Lee N.H. A Survey of Herbal Medicines as Tumor Microenvironment-Modulating Agents. Phytother. Res. 2021;35:78\u201394. doi: 10.1002/ptr.6784.", "ArticleIdList": ["10.1002/ptr.6784", "32658314"]}, {"Citation": "Cheon C. Synergistic Effects of Herbal Medicines and Anticancer Drugs A Protocol for Systematic Review and Meta-Analysis. Medicine. 2021;100:e27918. doi: 10.1097/MD.0000000000027918.", "ArticleIdList": ["10.1097/MD.0000000000027918", "PMC8601363", "34797348"]}, {"Citation": "Lin S.-R., Chang C.-H., Hsu C.-F., Tsai M.-J., Cheng H., Leong M.K., Sung P.-J., Chen J.-C., Weng C.-F. Natural Compounds as Potential Adjuvants to Cancer Therapy: Preclinical Evidence. Br. J. Pharmacol. 2019;177:1409\u20131423. doi: 10.1111/bph.14816.", "ArticleIdList": ["10.1111/bph.14816", "PMC7056458", "31368509"]}, {"Citation": "Ganesan K., Jayachandran M., Xu B. Diet-Derived Phytochemicals Targeting Colon Cancer Stem Cells and Microbiota in Colorectal Cancer. Int. J. Mol. Sci. 2020;21:3976. doi: 10.3390/ijms21113976.", "ArticleIdList": ["10.3390/ijms21113976", "PMC7312951", "32492917"]}, {"Citation": "Rahman M.A., Hannan M.A., Dash R., Rahman M.H., Islam R., Uddin M.J., Sohag A.A.M., Rahman M.H., Rhim H. Phytochemicals as a Complement to Cancer Chemotherapy: Pharmacological Modulation of the Autophagy-Apoptosis Pathway. Front. Pharmacol. 2021;12:639628. doi: 10.3389/fphar.2021.639628.", "ArticleIdList": ["10.3389/fphar.2021.639628", "PMC8138161", "34025409"]}, {"Citation": "Ahmed M.B., Islam S.U., Alghamdi A.A.A., Kamran M., Ahsan H., Lee Y.S. Phytochemicals as Chemo-Preventive Agents and Signaling Molecule Modulators: Current Role in Cancer Therapeutics and Inflammation. Int. J. Mol. Sci. 2022;23:15765. doi: 10.3390/ijms232415765.", "ArticleIdList": ["10.3390/ijms232415765", "PMC9779495", "36555406"]}, {"Citation": "Al-Yozbaki M., Wilkin P.J., Gupta G.K., Wilson C.M. Therapeutic Potential of Natural Compounds in Lung Cancer. Curr. Med. Chem. 2021;28:7988\u20138002. doi: 10.2174/0929867328666210322103906.", "ArticleIdList": ["10.2174/0929867328666210322103906", "33749551"]}, {"Citation": "Aung T.N., Qu Z., Kortschak R.D., Adelson D.L. Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action. Int. J. Mol. Sci. 2017;18:656. doi: 10.3390/ijms18030656.", "ArticleIdList": ["10.3390/ijms18030656", "PMC5372668", "28304343"]}, {"Citation": "Wattanathamsan O., Hayakawa Y., Pongrakhananon V. Molecular Mechanisms of Natural Compounds in Cell Death Induction and Sensitization to Chemotherapeutic Drugs in Lung Cancer. Phytother. Res. 2019;33:2531\u20132547. doi: 10.1002/ptr.6422.", "ArticleIdList": ["10.1002/ptr.6422", "31293008"]}, {"Citation": "Huang C.Y., Ju D.T., Chang C.F., Muralidhar Reddy P., Velmurugan B.K. A Review on the Effects of Current Chemotherapy Drugs and Natural Agents in Treating Non-Small Cell Lung Cancer. BioMedicine. 2017;7:12\u201323. doi: 10.1051/bmdcn/2017070423.", "ArticleIdList": ["10.1051/bmdcn/2017070423", "PMC5682982", "29130448"]}, {"Citation": "Carrasco-Pozo C., Avery V.M. Glycolytic Effect of Meat Metabolites: Role of Dietary Compounds and Their Microbiota-Derived Metabolites in the Prevention of Lung Cancer Development. ACS Food Sci. Technol. 2023;3:1496\u20131513. doi: 10.1021/acsfoodscitech.3c00194.", "ArticleIdList": ["10.1021/acsfoodscitech.3c00194"]}, {"Citation": "Duan J., Zhan J.C., Wang G.Z., Zhao X.C., Huang W.D., Zhou G.B. The Red Wine Component Ellagic Acid Induces Autophagy and Exhibits Anti-Lung Cancer Activity In Vitro and In Vivo. J. Cell. Mol. Med. 2019;23:143\u2013154. doi: 10.1111/jcmm.13899.", "ArticleIdList": ["10.1111/jcmm.13899", "PMC6307804", "30353639"]}, {"Citation": "Zhou H., Xu L., Shi Y., Gu S., Wu N., Liu F., Huang Y., Qian Z., Xue W., Wang X., et al. A Novel Myricetin Derivative with Anti-Cancer Properties Induces Cell Cycle Arrest and Apoptosis in A549 Cells. Biol. Pharm. Bull. 2023;46:42\u201351. doi: 10.1248/bpb.b22-00483.", "ArticleIdList": ["10.1248/bpb.b22-00483", "36596525"]}, {"Citation": "Zhang Y., Zhuang Z., Meng Q., Jiao Y., Xu J., Fan S. Polydatin Inhibits Growth of Lung Cancer Cells by Inducing Apoptosis and Causing Cell Cycle Arrest. Oncol. Lett. 2014;7:295\u2013301. doi: 10.3892/ol.2013.1696.", "ArticleIdList": ["10.3892/ol.2013.1696", "PMC3861602", "24348867"]}, {"Citation": "Wang W., Wu J., Zhang Q., Li X., Zhu X., Wang Q., Cao S., Du L. Mitochondria-Mediated Apoptosis Was Induced by Oleuropein in H1299 Cells Involving Activation of P38 MAP Kinase. J. Cell. Biochem. 2019;120:5480\u20135494. doi: 10.1002/jcb.27827.", "ArticleIdList": ["10.1002/jcb.27827", "30324629"]}, {"Citation": "Ma L., Wen Z.S., Liu Z., Hu Z., Ma J., Chen X.Q., Liu Y.Q., Pu J.X., Xiao W.L., Sun H.D., et al. Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer. PLoS ONE. 2011;6:e20159. doi: 10.1371/journal.pone.0020159.", "ArticleIdList": ["10.1371/journal.pone.0020159", "PMC3105001", "21655278"]}, {"Citation": "Wang Z., Yang L., Xia Y., Guo C., Kong L. Icariin Enhances Cytotoxicity of Doxorubicin in Human Multidrug-Resistant Osteosarcoma Cells by Inhibition of ABCB1 and Down-Regulation of the PI3K/Akt Pathway. Biol. Pharm. Bull. 2015;38:277\u2013284. doi: 10.1248/bpb.b14-00663.", "ArticleIdList": ["10.1248/bpb.b14-00663", "25747987"]}, {"Citation": "Liu Z., Ma L., Wen Z.S., Cheng Y.X., Zhou G.B. Ethoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2A in Lung Cancer Cells. ACS Med. Chem. Lett. 2014;5:113\u2013118. doi: 10.1021/ml400341k.", "ArticleIdList": ["10.1021/ml400341k", "PMC4027744", "24900782"]}, {"Citation": "Thai A.A., Solomon B.J., Sequist L.V., Gainor J.F., Heist R.S. Lung Cancer. Lancet. 2021;398:535\u2013554. doi: 10.1016/S0140-6736(21)00312-3.", "ArticleIdList": ["10.1016/S0140-6736(21)00312-3", "34273294"]}, {"Citation": "Klebe S., Leigh J., Henderson D.W., Nurminen M. Asbestos, Smoking and Lung Cancer: An Update. Int. J. Environ. Res. Public Health. 2020;17:258. doi: 10.3390/ijerph17010258.", "ArticleIdList": ["10.3390/ijerph17010258", "PMC6982078", "31905913"]}, {"Citation": "Alberg A.J., Brock M.V., Ford J.G., Samet J.M., Spivack S.D. Epidemiology of Lung Cancer. Chest. 2013;143:e1S\u2013e29S. doi: 10.1378/chest.12-2345.", "ArticleIdList": ["10.1378/chest.12-2345", "PMC4694610", "23649439"]}, {"Citation": "Croce C.M. Causes and Consequences of MicroRNA Dysregulation in Cancer. Nat. Rev. Genet. 2009;10:704\u2013714. doi: 10.1038/nrg2634.", "ArticleIdList": ["10.1038/nrg2634", "PMC3467096", "19763153"]}, {"Citation": "Mogi A., Kuwano H. TP53 Mutations in Nonsmall Cell Lung Cancer. J. Biomed. Biotechnol. 2011;2011:583929. doi: 10.1155/2011/583929.", "ArticleIdList": ["10.1155/2011/583929", "PMC3035360", "21331359"]}, {"Citation": "Penning T.M. Human Aldo-Keto Reductases and the Metabolic Activation of Polycyclic Aromatic Hydrocarbons. Chem. Res. Toxicol. 2014;27:1901\u20131917. doi: 10.1021/tx500298n.", "ArticleIdList": ["10.1021/tx500298n", "PMC4237494", "25279998"]}, {"Citation": "Miao S., Qiu H. The Microbiome in the Pathogenesis of Lung Cancer. APMIS. 2024;132:68\u201380. doi: 10.1111/apm.13359.", "ArticleIdList": ["10.1111/apm.13359", "37974493"]}, {"Citation": "Wen J., Fu J.H., Zhang W., Guo M. Lung Carcinoma Signaling Pathways Activated by Smoking. Chin. J. Cancer. 2011;30:551\u2013558. doi: 10.5732/cjc.011.10059.", "ArticleIdList": ["10.5732/cjc.011.10059", "PMC4013405", "21801603"]}, {"Citation": "Zhang N., Wei X., Xu L. MiR-150 Promotes the Proliferation of Lung Cancer Cells by Targeting P53. FEBS Lett. 2013;587:2346\u20132351. doi: 10.1016/j.febslet.2013.05.059.", "ArticleIdList": ["10.1016/j.febslet.2013.05.059", "23747308"]}, {"Citation": "Mithoowani H., Febbraro M. Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology. Curr. Oncol. 2022;29:1828\u20131839. doi: 10.3390/curroncol29030150.", "ArticleIdList": ["10.3390/curroncol29030150", "PMC8946954", "35323350"]}, {"Citation": "Inamura K. Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification. Front. Oncol. 2017;7:193. doi: 10.3389/fonc.2017.00193.", "ArticleIdList": ["10.3389/fonc.2017.00193", "PMC5581350", "28894699"]}, {"Citation": "Iqbal J., Abbasi B.A., Mahmood T., Kanwal S., Ali B., Shah S.A., Khalil A.T. Plant-Derived Anticancer Agents: A Green Anticancer Approach. Asian Pac. J. Trop. Biomed. 2017;7:1129\u20131150. doi: 10.1016/j.apjtb.2017.10.016.", "ArticleIdList": ["10.1016/j.apjtb.2017.10.016"]}, {"Citation": "Kuhn E., Morbini P., Cancellieri A., Damiani S., Cavazza A. Comin CE Adenocarcinoma Classification: Patterns and Prognosis. Pathologica. 2018;110:5\u201311.", "ArticleIdList": ["30259909"]}, {"Citation": "Borczuk A.C. Updates in Grading and Invasion Assessment in Lung Adenocarcinoma. Mod. Pathol. 2022;35:28\u201335. doi: 10.1038/s41379-021-00934-3.", "ArticleIdList": ["10.1038/s41379-021-00934-3", "34615984"]}, {"Citation": "Chen R., Ding Z., Zhu L., Lu S., Yu Y. Correlation of Clinicopathologic Features and Lung Squamous Cell Carcinoma Subtypes According to the 2015 WHO Classification. Eur. J. Surg. Oncol. 2017;43:2308\u20132314. doi: 10.1016/j.ejso.2017.09.011.", "ArticleIdList": ["10.1016/j.ejso.2017.09.011", "28964610"]}, {"Citation": "Chan A.W., Chau S.L., Tong J.H., Chow C., Kwan J.S.H., Chung L.Y., Lung R.W., Tong C.Y., Tin E.K., Law P.P., et al. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung. J. Thorac. Oncol. 2019;14:1213\u20131222. doi: 10.1016/j.jtho.2019.03.021.", "ArticleIdList": ["10.1016/j.jtho.2019.03.021", "30978501"]}, {"Citation": "Saltos A., Shafique M., Chiappori A. Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC) Front. Oncol. 2020;10:1074. doi: 10.3389/fonc.2020.01074.", "ArticleIdList": ["10.3389/fonc.2020.01074", "PMC7378389", "32766139"]}, {"Citation": "Rudin C.M., Brambilla E., Faivre-Finn C., Sage J. Small-Cell Lung Cancer. Nat. Rev. Dis. Primers. 2021;7:3. doi: 10.1038/s41572-020-00235-0.", "ArticleIdList": ["10.1038/s41572-020-00235-0", "PMC8177722", "33446664"]}, {"Citation": "Debela D.T., Muzazu S.G.Y., Heraro K.D., Ndalama M.T., Mesele B.W., Haile D.C., Kitui S.K., Manyazewal T. New Approaches and Procedures for Cancer Treatment: Current Perspectives. SAGE Open Med. 2021;9:20503121211034366. doi: 10.1177/20503121211034366.", "ArticleIdList": ["10.1177/20503121211034366", "PMC8366192", "34408877"]}, {"Citation": "Schabath M.B., Cress W.D., Mu\u00f1oz-Antonia T. Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer. Cancer Control. 2016;23:338\u2013346. doi: 10.1177/107327481602300405.", "ArticleIdList": ["10.1177/107327481602300405", "PMC5340153", "27842323"]}, {"Citation": "Gadgeel S.M., Kalemkerian G.P. Racial Differences in Lung Cancer. Cancer Metastasis Rev. 2003;22:39\u201346. doi: 10.1023/A:1022207917249.", "ArticleIdList": ["10.1023/A:1022207917249", "12716035"]}, {"Citation": "Zhu M., Lv J., Huang Y., Ma H., Li N., Wei X., Ji M., Ma Z., Song C., Wang C., et al. Ethnic Differences of Genetic Risk and Smoking in Lung Cancer: Two Prospective Cohort Studies. Int. J. Epidemiol. 2023;52:1815\u20131825. doi: 10.1093/ije/dyad118.", "ArticleIdList": ["10.1093/ije/dyad118", "37676847"]}, {"Citation": "Hu M., Tan J., Liu Z., Li L., Zhang H., Zhao D., Li B., Gao X., Che N., Zhang T. Comprehensive Comparative Molecular Characterization of Young and Old Lung Cancer Patients. Front. Oncol. 2022;11:806845. doi: 10.3389/fonc.2021.806845.", "ArticleIdList": ["10.3389/fonc.2021.806845", "PMC8789686", "35096611"]}, {"Citation": "Cho W.K., Lee C.G., Kim L.K. COPD as a Disease of Immunosenescence. Yonsei Med. J. 2019;60:407\u2013413. doi: 10.3349/ymj.2019.60.5.407.", "ArticleIdList": ["10.3349/ymj.2019.60.5.407", "PMC6479124", "31016901"]}, {"Citation": "Paudel K.R., Dharwal V., Patel V.K., Galvao I., Wadhwa R., Malyla V., Shen S.S., Budden K.F., Hansbro N.G., Vaughan A., et al. Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases. Front. Med. 2020;7:554. doi: 10.3389/fmed.2020.00554.", "ArticleIdList": ["10.3389/fmed.2020.00554", "PMC7530186", "33043031"]}, {"Citation": "Liu M., Liu X., Suo P., Gong Y., Qu B., Peng X., Xiao W., Li Y., Chen Y., Zeng Z., et al. The Contribution of Hereditary Cancer-Related Germline Mutations to Lung Cancer Susceptibility. Transl. Lung Cancer Res. 2020;9:646\u2013658. doi: 10.21037/tlcr-19-403.", "ArticleIdList": ["10.21037/tlcr-19-403", "PMC7354149", "32676327"]}, {"Citation": "Birru R.L., Peter Di Y. Pathogenic Mechanism of Second Hand Smoke Induced Inflammation and COPD. Front. Physiol. 2012;3:348. doi: 10.3389/fphys.2012.00348.", "ArticleIdList": ["10.3389/fphys.2012.00348", "PMC3428782", "22973236"]}, {"Citation": "Borie R., Funalot B., Epaud R., Delestrain C., Cazes A., Gounant V., Frija J., Debray M.P., Zalcman G., Crestani B. NKX2.1 (TTF1) Germline Mutation Associated with Pulmonary Fibrosis and Lung Cancer. ERJ Open Res. 2021;7:00356-2021. doi: 10.1183/23120541.00356-2021.", "ArticleIdList": ["10.1183/23120541.00356-2021", "PMC8573227", "34760996"]}, {"Citation": "Lee S.H. Chemotherapy for Lung Cancer in the Era of Personalized Medicine. Tuberc. Respir. Dis. 2019;82:179\u2013189. doi: 10.4046/trd.2018.0068.", "ArticleIdList": ["10.4046/trd.2018.0068", "PMC6609523", "30841023"]}, {"Citation": "Pirker R. Chemotherapy Remains a Cornerstone in the Treatment of Nonsmall Cell Lung Cancer. Curr. Opin. Oncol. 2020;32:63\u201367. doi: 10.1097/CCO.0000000000000592.", "ArticleIdList": ["10.1097/CCO.0000000000000592", "31599771"]}, {"Citation": "Nagasaka M., Gadgeel S.M. Role of Chemotherapy and Targeted Therapy in Early-Stage Non-Small Cell Lung Cancer. Expert Rev. Anticancer. Ther. 2018;18:63\u201370. doi: 10.1080/14737140.2018.1409624.", "ArticleIdList": ["10.1080/14737140.2018.1409624", "PMC6863145", "29168933"]}, {"Citation": "Kuribayashi K., Funaguchi N., Nakano T. Chemotherapy for Advanced Non-Small Cell Lung Cancer with a Focus on Squamous Cell Carcinoma. J. Cancer Res. Ther. 2016;12:528\u2013534. doi: 10.4103/0973-1482.174185.", "ArticleIdList": ["10.4103/0973-1482.174185", "27461605"]}, {"Citation": "Pento J.T. Monoclonal Antibodies for the Treatment of Cancer. Anticancer. Res. 2017;37:5935\u20135939.", "ArticleIdList": ["29061772"]}, {"Citation": "Weiner L.M., Surana R., Wang S. Monoclonal Antibodies: Versatile Platforms for Cancer Immunotherapy. Nat. Rev. Immunol. 2010;10:317\u2013327. doi: 10.1038/nri2744.", "ArticleIdList": ["10.1038/nri2744", "PMC3508064", "20414205"]}, {"Citation": "Metro G., Baglivo S., Moretti R., Bellezza G., Sidoni A., Roila F. Is There a Role for Multiple Lines of Anti-HER2 Therapies Administered Beyond Progression in HER2-Mutated Non-Small Cell Lung Cancer? A Case Report and Literature Review. Oncol. Ther. 2020;8:341\u2013350. doi: 10.1007/s40487-020-00121-5.", "ArticleIdList": ["10.1007/s40487-020-00121-5", "PMC7683654", "32700047"]}, {"Citation": "Tsiouprou I., Zaharias A., Spyratos D. The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature. Can. Respir. J. 2019;2019:6860432. doi: 10.1155/2019/6860432.", "ArticleIdList": ["10.1155/2019/6860432", "PMC6875088", "31781314"]}, {"Citation": "Kim T.H., Park S.H., Hwang I., Lee J.H., Kim J.H., Kim H.W., Kim H.J. Robust Response of Pulmonary Pleomorphic Carcinoma to Pembrolizumab and Sequential Radiotherapy: A Case Report. Respirol. Case Rep. 2021;9:e0875. doi: 10.1002/rcr2.875.", "ArticleIdList": ["10.1002/rcr2.875", "PMC8580814", "34795901"]}, {"Citation": "Yang S., Zhang Z., Wang Q. Emerging Therapies for Small Cell Lung Cancer. J. Hematol. Oncol. 2019;12:47. doi: 10.1186/s13045-019-0736-3.", "ArticleIdList": ["10.1186/s13045-019-0736-3", "PMC6498593", "31046803"]}, {"Citation": "Bansal P., Osman D., Gan G.N., Simon G.R., Boumber Y. Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC. Front. Oncol. 2016;6:112. doi: 10.3389/fonc.2016.00112.", "ArticleIdList": ["10.3389/fonc.2016.00112", "PMC4854869", "27200298"]}, {"Citation": "Marei H.E., Cenciarelli C., Hasan A. Potential of Antibody\u2013Drug Conjugates (ADCs) for Cancer Therapy. Cancer Cell Int. 2022;22:255. doi: 10.1186/s12935-022-02679-8.", "ArticleIdList": ["10.1186/s12935-022-02679-8", "PMC9375290", "35964048"]}, {"Citation": "Kim E.S. Chemotherapy Resistance in Lung Cancer. Adv. Exp. Med. Biol. 2016;893:189\u2013209. doi: 10.1007/978-3-319-24223-1_10.", "ArticleIdList": ["10.1007/978-3-319-24223-1_10", "26667345"]}, {"Citation": "Suda K., Mitsudomi T. Successes and Limitations of Targeted Cancer Therapy in Lung Cancer. Prog. Tumor Res. 2014;41:62\u201377.", "ArticleIdList": ["24727987"]}, {"Citation": "Zimmermann S., Dziadziuszko R., Peters S. Indications and Limitations of Chemotherapy and Targeted Agents in Non-Small Cell Lung Cancer Brain Metastases. Cancer Treat. Rev. 2014;40:716\u2013722. doi: 10.1016/j.ctrv.2014.03.005.", "ArticleIdList": ["10.1016/j.ctrv.2014.03.005", "24759599"]}, {"Citation": "Petrovska B.B. Historical Review of Medicinal Plants\u2019 Usage. Pharmacogn. Rev. 2012;6:1\u20135. doi: 10.4103/0973-7847.95849.", "ArticleIdList": ["10.4103/0973-7847.95849", "PMC3358962", "22654398"]}, {"Citation": "Banerjee S., Nau S., Hochwald S.N., Xie H., Zhang J. Anticancer Properties and Mechanisms of Botanical Derivatives. Phytomedicine Plus. 2023;3:100396. doi: 10.1016/j.phyplu.2022.100396.", "ArticleIdList": ["10.1016/j.phyplu.2022.100396"]}, {"Citation": "Ali Abdalla Y.O., Subramaniam B., Nyamathulla S., Shamsuddin N., Arshad N.M., Mun K.S., Awang K., Nagoor N.H. Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade. J. Trop. Med. 2022;2022:5794350. doi: 10.1155/2022/5794350.", "ArticleIdList": ["10.1155/2022/5794350", "PMC8933079", "35309872"]}, {"Citation": "Khan A.W., Farooq M., Haseeb M., Choi S. Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action. Cells. 2022;11:1326. doi: 10.3390/cells11081326.", "ArticleIdList": ["10.3390/cells11081326", "PMC9031068", "35456005"]}, {"Citation": "Jongrungraungchok S., Madaka F., Wunnakup T., Sudsai T., Pongphaew C., Songsak T., Pradubyat N. In Vitro Antioxidant, Anti-Inflammatory, and Anticancer Activities of Mixture Thai Medicinal Plants. BMC Complement. Med. Ther. 2023;23:43. doi: 10.1186/s12906-023-03862-8.", "ArticleIdList": ["10.1186/s12906-023-03862-8", "PMC9912591", "36765341"]}, {"Citation": "Hoseinkhani Z., Norooznezhad F., Rastegari-Pouyani M., Mansouri K. Medicinal Plants Extracts with Antiangiogenic Activity: Where Is the Link? Adv. Pharm. Bull. 2020;10:370\u2013378. doi: 10.34172/apb.2020.045.", "ArticleIdList": ["10.34172/apb.2020.045", "PMC7335987", "32665895"]}, {"Citation": "Ullah M.F., Abuduhier F.M., Bhat S.H., Ahmad A., Ajmal M.R., Mustafa S.K. Cytotoxic and Anti-Metastatic Action Mediates the Anti-Proliferative Activity of Rhazya Stricta Decne Inducing Apoptotic Cell Death in Human Cancer Cells: Implication in Chemopreventive Mechanism. Emir. J. Food Agric. 2023;35:683\u2013692. doi: 10.9755/ejfa.2023.3132.", "ArticleIdList": ["10.9755/ejfa.2023.3132"]}, {"Citation": "Memarzia A., Saadat S., Asgharzadeh F., Behrouz S., Folkerts G., Boskabady M.H. Therapeutic Effects of Medicinal Plants and Their Constituents on Lung Cancer, In Vitro, In Vivo and Clinical Evidence. J. Cell. Mol. Med. 2023;27:2841\u20132863. doi: 10.1111/jcmm.17936.", "ArticleIdList": ["10.1111/jcmm.17936", "PMC10538270", "37697969"]}, {"Citation": "Zagni C., Floresta G., Monciino G., Rescifina A. The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat. Med. Res. Rev. 2017;37:1373\u20131428. doi: 10.1002/med.21437.", "ArticleIdList": ["10.1002/med.21437", "28181261"]}, {"Citation": "Imran M., Aslam Gondal T., Atif M., Shahbaz M., Batool Qaisarani T., Hanif Mughal M., Salehi B., Martorell M., Sharifi-Rad J. Apigenin as an Anticancer Agent. Phytother. Res. 2020;34:1812\u20131828. doi: 10.1002/ptr.6647.", "ArticleIdList": ["10.1002/ptr.6647", "32059077"]}, {"Citation": "Yan W., Wu T.H.Y., Leung S.S.Y., To K.K.W. Flavonoids Potentiated Anticancer Activity of Cisplatin in Non-Small Cell Lung Cancer Cells In Vitro by Inhibiting Histone Deacetylases. Life Sci. 2020;258:118211. doi: 10.1016/j.lfs.2020.118211.", "ArticleIdList": ["10.1016/j.lfs.2020.118211", "32768576"]}, {"Citation": "Sak K. Chemotherapy and Dietary Phytochemical Agents. Chemother. Res. Pract. 2012;2012:282570. doi: 10.1155/2012/282570.", "ArticleIdList": ["10.1155/2012/282570", "PMC3539428", "23320169"]}, {"Citation": "Hill R.A., Connolly J.D. Triterpenoids. Nat. Prod. Rep. 2013;30:1028\u20131065. doi: 10.1039/C3NP70032A.", "ArticleIdList": ["10.1039/C3NP70032A", "23736383"]}, {"Citation": "Connolly J.D., Hill R.A. Triterpenoids. Nat. Prod. Rep. 2010;27:79\u2013132. doi: 10.1039/B808530G.", "ArticleIdList": ["10.1039/B808530G", "20024095"]}, {"Citation": "Fang K., Zhang X.H., Han Y.T., Wu G.R., Cai D.S., Xue N.N., Guo W.B., Yang Y.Q., Chen M., Zhang X.Y., et al. Design, Synthesis, and Cytotoxic Analysis of Novel Hederagenin\u2013Pyrazine Derivatives Based on Partial Least Squares Discriminant Analysis. Int. J. Mol. Sci. 2018;19:2994. doi: 10.3390/ijms19102994.", "ArticleIdList": ["10.3390/ijms19102994", "PMC6213900", "30274380"]}, {"Citation": "Manghwar H., Hussain A., Ali Q., Liu F. Brassinosteroids (BRs) Role in Plant Development and Coping with Different Stresses. Int. J. Mol. Sci. 2022;23:1012. doi: 10.3390/ijms23031012.", "ArticleIdList": ["10.3390/ijms23031012", "PMC8835148", "35162936"]}, {"Citation": "Masi M., Van Slambrouck S., Gunawardana S., van Rensburg M.J., James P.C., Mochel J.G., Heliso P.S., Albalawi A.S., Cimmino A., van Otterlo W.A.L., et al. Alkaloids Isolated from Haemanthus Humilis Jacq., an Indigenous South African Amaryllidaceae: Anticancer Activity of Coccinine and Montanine. S. Afr. J. Bot. 2019;126:277\u2013281. doi: 10.1016/j.sajb.2019.01.036.", "ArticleIdList": ["10.1016/j.sajb.2019.01.036"]}, {"Citation": "Sinha D. A Review on Taxanes: An Important Group of Anticancer Compound Obtained from Taxus sp. Int. J. Pharm. Sci. Res. 2020;11:1969\u20131985. doi: 10.13040/IJPSR.0975-8232.11(5).1969-85.", "ArticleIdList": ["10.13040/IJPSR.0975-8232.11(5).1969-85"]}, {"Citation": "Alsaif G., Tasleem M., Rezgui R., Alshaghdali K., Saeed A., Saeed M. Network Pharmacology and Molecular Docking Analysis of Catharanthus Roseus Compounds: Implications for Non-Small Cell Lung Cancer Treatment. J. King Saud Univ. Sci. 2024;36:103134. doi: 10.1016/j.jksus.2024.103134.", "ArticleIdList": ["10.1016/j.jksus.2024.103134"]}, {"Citation": "Singh N., Agrawal P. A Comprehensive Review on the Pharmacognostic and Toxicological Profile of Podophyllum peltatum (Bajiaolian) Pharmacol. Res.-Mod. Chin. Med. 2024;10:100353. doi: 10.1016/j.prmcm.2023.100353.", "ArticleIdList": ["10.1016/j.prmcm.2023.100353"]}, {"Citation": "Fan X., Lin X., Ruan Q., Wang J., Yang Y., Sheng M., Zhou W., Kai G., Hao X. Research Progress on the Biosynthesis and Metabolic Engineering of the Anti-Cancer Drug Camptothecin in Camptotheca Acuminate. Ind. Crops Prod. 2022;186:115270. doi: 10.1016/j.indcrop.2022.115270.", "ArticleIdList": ["10.1016/j.indcrop.2022.115270"]}, {"Citation": "Okem A., Henstra C., Lambert M., Hayeshi R. A Review of the Pharmacodynamic Effect of Chemo-Herbal Drug Combinations Therapy for Cancer Treatment. Med. Drug Discov. 2023;17:100147. doi: 10.1016/j.medidd.2022.100147.", "ArticleIdList": ["10.1016/j.medidd.2022.100147"]}, {"Citation": "Dai Y., Wang W., Sun Q., Tuohayi J. Ginsenoside Rg3 Promotes the Antitumor Activity of Gefitinib in Lung Cancer Cell Lines. Exp. Ther. Med. 2018;17:953\u2013959. doi: 10.3892/etm.2018.7001.", "ArticleIdList": ["10.3892/etm.2018.7001", "PMC6307378", "30651886"]}, {"Citation": "Tan Q., Lin S., Zeng Y., Yao M., Liu K., Yuan H., Liu C., Jiang G. Ginsenoside Rg3 Attenuates the Osimertinib Resistance by Reducing the Stemness of Non-Small Cell Lung Cancer Cells. Environ. Toxicol. 2020;35:643\u2013651. doi: 10.1002/tox.22899.", "ArticleIdList": ["10.1002/tox.22899", "31916386"]}, {"Citation": "Sun M., Ye Y., Xiao L., Duan X., Zhang Y., Zhang H. Anticancer Effects of Ginsenoside Rg3 (Review) Int. J. Mol. Med. 2017;39:507\u2013518. doi: 10.3892/ijmm.2017.2857.", "ArticleIdList": ["10.3892/ijmm.2017.2857", "28098857"]}, {"Citation": "Kang J.I., Hong J.Y., Lee H.J., Bae S.Y., Jung C., Park H.J., Lee S.K. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/MTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells. PLoS ONE. 2015;10:e0144368. doi: 10.1371/journal.pone.0144368.", "ArticleIdList": ["10.1371/journal.pone.0144368", "PMC4676678", "26656173"]}, {"Citation": "Jung C.Y., Kim S.Y., Lee C. Carvacrol Targets AXL to Inhibit Cell Proliferation and Migration in Non-Small Cell Lung Cancer Cells. Anticancer. Res. 2018;38:279\u2013286. doi: 10.21873/anticanres.12219.", "ArticleIdList": ["10.21873/anticanres.12219", "29277784"]}, {"Citation": "Yan Y.F., Zhang H.H., Lv Q., Liu Y.M., Li Y.J., Li B.S., Wang P.Y., Shang W.J., Yue Z., Xie S.Y. Celastrol Suppresses the Proliferation of Lung Adenocarcinoma Cells by Regulating MicroRNA-24 and MicroRNA-181b. Oncol. Lett. 2018;15:2515\u20132521. doi: 10.3892/ol.2017.7593.", "ArticleIdList": ["10.3892/ol.2017.7593", "PMC5777372", "29434967"]}, {"Citation": "Sun Y., Wu P., Sun Y., Sharopov F.S., Yang Q., Chen F., Wang P., Liang Z. Lycorine Possesses Notable Anticancer Potentials in On-Small Cell Lung Carcinoma Cells via Blocking Wnt/\u03b2-Catenin Signaling and Epithelial-Mesenchymal Transition (EMT) Biochem. Biophys. Res. Commun. 2018;495:911\u2013921. doi: 10.1016/j.bbrc.2017.11.032.", "ArticleIdList": ["10.1016/j.bbrc.2017.11.032", "29127013"]}, {"Citation": "Baek S.H., Ko J.H., Lee J.H., Kim C., Lee H., Nam D., Lee J., Lee S.G., Yang W.M., Um J.Y., et al. Ginkgolic Acid Inhibits Invasion and Migration and TGF-\u03b2-Induced EMT of Lung Cancer Cells Through PI3K/Akt/MTOR Inactivation. J. Cell. Physiol. 2017;232:346\u2013354. doi: 10.1002/jcp.25426.", "ArticleIdList": ["10.1002/jcp.25426", "27177359"]}, {"Citation": "Yesil-Celiktas O., Sevimli C., Bedir E., Vardar-Sukan F. Inhibitory Effects of Rosemary Extracts, Carnosic Acid, and Rosmarinic Acid on the Growth of Various Human Cancer Cell Lines. Plant Foods Hum. Nutr. 2010;65:158\u2013163. doi: 10.1007/s11130-010-0166-4.", "ArticleIdList": ["10.1007/s11130-010-0166-4", "20449663"]}, {"Citation": "Lee J.H., Kim C., Lee S.G., Yang W.M., Um J.Y., Sethi G., Ahn K.S. Ophiopogonin D Modulates Multiple Oncogenic Signaling Pathways, Leading to Suppression of Proliferation and Chemosensitization of Human Lung Cancer Cells. Phytomedicine. 2018;40:165\u2013175. doi: 10.1016/j.phymed.2018.01.002.", "ArticleIdList": ["10.1016/j.phymed.2018.01.002", "29496169"]}, {"Citation": "Manjamalai A., Berlin Grace V.M. Antioxidant Activity of Essential Oils from Wedelia Chinensis (Osbeck) In Vitro and In Vivo Lung Cancer Bearing C57BL/6 Mice. Asian Pac. J. Cancer Prev. 2012;13:3065\u20133071. doi: 10.7314/APJCP.2012.13.7.3065.", "ArticleIdList": ["10.7314/APJCP.2012.13.7.3065", "22994711"]}, {"Citation": "Petpiroon N., Bhummaphan N., Tungsukruthai S., Pinkhien T., Maiuthed A., Sritularak B., Chanvorachote P. Chrysotobibenzyl Inhibition of Lung Cancer Cell Migration through Caveolin-1-Dependent Mediation of the Integrin Switch and the Sensitization of Lung Cancer Cells to Cisplatin-Mediated Apoptosis. Phytomedicine. 2019;58:152888. doi: 10.1016/j.phymed.2019.152888.", "ArticleIdList": ["10.1016/j.phymed.2019.152888", "30901662"]}, {"Citation": "Liu X., Zhao T., Shi Z., Hu C., Li Q., Sun C. Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells. Molecules. 2023;28:4947. doi: 10.3390/molecules28134947.", "ArticleIdList": ["10.3390/molecules28134947", "PMC10343727", "37446609"]}, {"Citation": "Cao J., Xia X., Chen X., Xiao J., Wang Q. Characterization of Flavonoids from Dryopteris Erythrosora and Evaluation of Their Antioxidant, Anticancer and Acetylcholinesterase Inhibition Activities. Food Chem. Toxicol. 2013;51:242\u2013250. doi: 10.1016/j.fct.2012.09.039.", "ArticleIdList": ["10.1016/j.fct.2012.09.039", "23063594"]}, {"Citation": "Pandey R.P., Gurung R.B., Sohng J.K. Apigenin and Naringenin: Natural Sources, Pharmacology and Role in Cancer Prevention. Nova Science Publishers; Hauppauge, NY, USA: 2015. Dietary Sources, Bioavailability and Biological Activities of Naringenin and Its Derivatives; pp. 151\u2013172."}, {"Citation": "Greco W.R., Faessel H., Levasseur L. EDITORIALS The Search for Cytotoxic Synergy Between Anticancer Agents: A Case of Dorothy and the Ruby Slippers? J. Natl. Cancer Inst. 1996;88:699\u2013700. doi: 10.1093/jnci/88.11.699.", "ArticleIdList": ["10.1093/jnci/88.11.699", "8637018"]}, {"Citation": "Roell K.R., Reif D.M., Motsinger-Reif A.A. An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from across Disciplines. Front. Pharmacol. 2017;8:158. doi: 10.3389/fphar.2017.00158.", "ArticleIdList": ["10.3389/fphar.2017.00158", "PMC5397413", "28473769"]}, {"Citation": "Pezzani R., Salehi B., Vitalini S., Iriti M., Zu\u00f1iga F.A., Sharifi-Rad J., Martorell M., Martins N. Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective. Medicina. 2019;55:110. doi: 10.3390/medicina55040110.", "ArticleIdList": ["10.3390/medicina55040110", "PMC6524059", "30999703"]}, {"Citation": "Foucquier J., Guedj M. Analysis of Drug Combinations: Current Methodological Landscape. Pharmacol. Res. Perspect. 2015;3:e00149. doi: 10.1002/prp2.149.", "ArticleIdList": ["10.1002/prp2.149", "PMC4492765", "26171228"]}, {"Citation": "Martinelli V. Combination Therapy. Neurol. Sci. 2006;27:s350\u2013s354. doi: 10.1007/s10072-006-0692-x.", "ArticleIdList": ["10.1007/s10072-006-0692-x", "16998718"]}, {"Citation": "Zhong W., Qin Y., Chen S., Sun T. A Global Scientific Vision-Prevention, Diagnosis, and Treatment of Lung Cancer. InTech; Rijeka, Croatia: 2017. Antitumor Effect of Natural Product Molecules against Lung Cancer."}, {"Citation": "Ying H.Z., Yu C.H., Chen H.K., Zhang H.H., Fang J., Wu F., Yu W.Y. Quinonoids: Therapeutic Potential for Lung Cancer Treatment. BioMed Res. Int. 2020;2020:2460565. doi: 10.1155/2020/2460565.", "ArticleIdList": ["10.1155/2020/2460565", "PMC7166295", "32337232"]}, {"Citation": "Kang J.H., Kang H.S., Kim I.K., Lee H.Y., Ha J.H., Yeo C.D., Kang H.H., Moon H.S., Lee S.H. Curcumin Sensitizes Human Lung Cancer Cells to Apoptosis and Metastasis Synergistically Combined with Carboplatin. Exp. Biol. Med. 2015;240:1416\u20131425. doi: 10.1177/1535370215571881.", "ArticleIdList": ["10.1177/1535370215571881", "PMC4935310", "25716014"]}, {"Citation": "Xu X.M., Zhang Y., Qu D., Liu H.B., Gu X., Jiao G.Y., Zhao L. Combined Anticancer Activity of Osthole and Cisplatin in NCI-H460 Lung Cancer Cells In Vitro. Exp. Ther. Med. 2013;5:707\u2013710. doi: 10.3892/etm.2013.889.", "ArticleIdList": ["10.3892/etm.2013.889", "PMC3570148", "23404433"]}, {"Citation": "Gavrilas L.I., Cruceriu D., Mocan A., Loghin F., Miere D., Balacescu O. Plant-Derived Bioactive Compounds in Colorectal Cancer: Insights from Combined Regimens with Conventional Chemotherapy to Overcome Drug-Resistance. Biomedicines. 2022;10:1948. doi: 10.3390/biomedicines10081948.", "ArticleIdList": ["10.3390/biomedicines10081948", "PMC9406120", "36009495"]}, {"Citation": "Han S.Y., Zhao M.B., Zhuang G.B., Li P.P. Marsdenia Tenacissima Extract Restored Gefitinib Sensitivity in Resistant Non-Small Cell Lung Cancer Cells. Lung Cancer. 2012;75:30\u201337. doi: 10.1016/j.lungcan.2011.06.001.", "ArticleIdList": ["10.1016/j.lungcan.2011.06.001", "21757251"]}, {"Citation": "Wang X., Yan Y., Chen X., Zeng S., Qian L., Ren X., Wei J., Yang X., Zhou Y., Gong Z., et al. The Antitumor Activities of Marsdenia Tenacissima. Front. Oncol. 2018;8:473. doi: 10.3389/fonc.2018.00473.", "ArticleIdList": ["10.3389/fonc.2018.00473", "PMC6206208", "30406035"]}, {"Citation": "Chen J.M., Yang T.T., Cheng T.S., Hsiao T.F., Chang P.M.H., Leu J.Y., Wang F.S., Hsu S.L., Huang C.Y.F., Lai J.M. Modified Sijunzi Decoction Can Alleviate Cisplatin-Induced Toxicity and Prolong the Survival Time of Cachectic Mice by Recovering Muscle Atrophy. J. Ethnopharmacol. 2019;233:47\u201355. doi: 10.1016/j.jep.2018.12.035.", "ArticleIdList": ["10.1016/j.jep.2018.12.035", "30590199"]}, {"Citation": "Jiang R.-Y., Fang Z.-R., Zhang H.-P., Xu J.-Y., Zhu J.-Y., Chen K.-Y., Wang W., Jiang X., Wang X.-J. Ginsenosides: Changing the Basic Hallmarks of Cancer Cells to Achieve the Purpose of Treating Breast Cancer. Chin. Med. 2023;18:125. doi: 10.1186/s13020-023-00822-9.", "ArticleIdList": ["10.1186/s13020-023-00822-9", "PMC10518937", "37749560"]}, {"Citation": "Kong F., Zhang R., Zhao X., Zheng G., Wang Z., Wang P. Resveratrol Raises In Vitro Anticancer Effects of Paclitaxel in NSCLC Cell Line A549 through COX-2 Expression. Korean J. Physiol. Pharmacol. 2017;21:465\u2013474. doi: 10.4196/kjpp.2017.21.5.465.", "ArticleIdList": ["10.4196/kjpp.2017.21.5.465", "PMC5587597", "28883751"]}, {"Citation": "Li Y., Chen X., He W., Xia S., Jiang X., Li X., Bai J., Li N., Chen L., Yang B. Apigenin Enhanced Antitumor Effect of Cisplatin in Lung Cancer via Inhibition of Cancer Stem Cells. Nutr. Cancer. 2021;73:1489\u20131497. doi: 10.1080/01635581.2020.1802494.", "ArticleIdList": ["10.1080/01635581.2020.1802494", "32757802"]}, {"Citation": "Chen Y.K., Wang H.C., Ho C.T., Chen H.Y., Li S., Chan H.L., Chung T.W., Tan K.T., Li Y.R., Lin C.C. 5-Demethylnobiletin Promotes the Formation of Polymerized Tubulin, Leads to G2/M Phase Arrest and Induces Autophagy via JNK Activation in Human Lung Cancer Cells. J. Nutr. Biochem. 2015;26:484\u2013504. doi: 10.1016/j.jnutbio.2014.12.003.", "ArticleIdList": ["10.1016/j.jnutbio.2014.12.003", "25765513"]}, {"Citation": "Guo S., Zhang Y., Wu Z., Zhang L., He D., Li X., Wang Z. Synergistic Combination Therapy of Lung Cancer: Cetuximab Functionalized Nanostructured Lipid Carriers for the Co-Delivery of Paclitaxel and 5-Demethylnobiletin. Biomed. Pharmacother. 2019;118:109225. doi: 10.1016/j.biopha.2019.109225.", "ArticleIdList": ["10.1016/j.biopha.2019.109225", "31325705"]}, {"Citation": "Klimaszewska-Wisniewska A., Halas-Wisniewska M., Tadrowski T., Gagat M., Grzanka D., Grzanka A. Paclitaxel and the Dietary Flavonoid Fisetin: A Synergistic Combination That Induces Mitotic Catastrophe and Autophagic Cell Death in A549 Non-Small Cell Lung Cancer Cells. Cancer Cell Int. 2016;16:10. doi: 10.1186/s12935-016-0288-3.", "ArticleIdList": ["10.1186/s12935-016-0288-3", "PMC4754822", "26884726"]}, {"Citation": "Wang K., Liu X., Liu Q., Ho I.H., Wei X., Yin T., Zhan Y., Zhang W., Zhang W., Chen B., et al. Hederagenin Potentiated Cisplatin- and Paclitaxel-Mediated Cytotoxicity by Impairing Autophagy in Lung Cancer Cells. Cell Death Dis. 2020;11:611. doi: 10.1038/s41419-020-02880-5.", "ArticleIdList": ["10.1038/s41419-020-02880-5", "PMC7426971", "32792495"]}, {"Citation": "Zhao L., Wen Q., Yang G., Huang Z., Shen T., Li H., Ren D. Apoptosis Induction of Dehydrobruceine B on Two Kinds of Human Lung Cancer Cell Lines through Mitochondrial-Dependent Pathway. Phytomedicine. 2016;23:114\u2013122. doi: 10.1016/j.phymed.2015.12.019.", "ArticleIdList": ["10.1016/j.phymed.2015.12.019", "26926172"]}, {"Citation": "Huang Z., Yang G., Shen T., Wang X., Li H., Ren D. Dehydrobruceine B Enhances the Cisplatin-Induced Cytotoxicity through Regulation of the Mitochondrial Apoptotic Pathway in Lung Cancer A549 Cells. Biomed. Pharmacother. 2017;89:623\u2013631. doi: 10.1016/j.biopha.2017.02.055.", "ArticleIdList": ["10.1016/j.biopha.2017.02.055", "28262615"]}, {"Citation": "Marostica L.L., de Barros A.L.B., Oliveira J., Salgado B.S., Cassali G.D., Leite E.A., Cardoso V.N., Lang K.L., Caro M.S.B., Dur\u00e1n F.J., et al. Antitumor Effectiveness of a Combined Therapy with a New Cucurbitacin B Derivative and Paclitaxel on a Human Lung Cancer Xenograft Model. Toxicol. Appl. Pharmacol. 2017;329:272\u2013281. doi: 10.1016/j.taap.2017.06.007.", "ArticleIdList": ["10.1016/j.taap.2017.06.007", "28610991"]}, {"Citation": "Satar N.A., Ismail M.N., Yahaya B.H. Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-like Population Derived from Non-Small Cell Lung Cancer Cell Lines. Molecules. 2021;26:1056. doi: 10.3390/molecules26041056.", "ArticleIdList": ["10.3390/molecules26041056", "PMC7922800", "33670440"]}, {"Citation": "Jiang Z., Yang Y., Yang Y., Zhang Y., Yue Z., Pan Z., Ren X. Ginsenoside Rg3 Attenuates Cisplatin Resistance in Lung Cancer by Downregulating PD-L1 and Resuming Immune. Biomed. Pharmacother. 2017;96:378\u2013383. doi: 10.1016/j.biopha.2017.09.129.", "ArticleIdList": ["10.1016/j.biopha.2017.09.129", "29031195"]}, {"Citation": "Tan K.T., Li S., Li Y.R., Cheng S.L., Lin S.H., Tung Y.T. Synergistic Anticancer Effect of a Combination of Paclitaxel and 5-Demethylnobiletin Against Lung Cancer Cell Line In Vitro and In Vivo. Appl. Biochem. Biotechnol. 2019;187:1328\u20131343. doi: 10.1007/s12010-018-2869-1.", "ArticleIdList": ["10.1007/s12010-018-2869-1", "30229430"]}, {"Citation": "Ren Q., Tao S., Guo F., Wang B., Yang L., Ma L., Fu P. Natural Flavonol Fisetin Attenuated Hyperuricemic Nephropathy via Inhibiting IL-6/JAK2/STAT3 and TGF-\u03b2/SMAD3 Signaling. Phytomedicine. 2021;87:153552. doi: 10.1016/j.phymed.2021.153552.", "ArticleIdList": ["10.1016/j.phymed.2021.153552", "33994251"]}, {"Citation": "Takagi K., Park E., Kato H. Anti-Inflammatory Activities of Hederagenin and Crude Saponin Isolated from Sapindus Mukorossi GAERTN. Chem. Pharm. Bull. 1980;28:1183\u20131188. doi: 10.1248/cpb.28.1183.", "ArticleIdList": ["10.1248/cpb.28.1183", "7418110"]}, {"Citation": "Gauthier C., Legault J., Girard-Lalancette K., Mshvildadze V., Pichette A. Haemolytic Activity, Cytotoxicity and Membrane Cell Permeabilization of Semi-Synthetic and Natural Lupane- and Oleanane-Type Saponins. Bioorg Med. Chem. 2009;17:2002\u20132008. doi: 10.1016/j.bmc.2009.01.022.", "ArticleIdList": ["10.1016/j.bmc.2009.01.022", "19200744"]}, {"Citation": "Rodr\u00edguez-Hern\u00e1ndez D., Demuner A.J., Barbosa L.C.A., Csuk R., Heller L. Hederagenin as a Triterpene Template for the Development of New Antitumor Compounds. Eur. J. Med. Chem. 2015;105:57\u201362. doi: 10.1016/j.ejmech.2015.10.006.", "ArticleIdList": ["10.1016/j.ejmech.2015.10.006", "26476750"]}, {"Citation": "Yang B., Chen Y., Shi J. Reactive Oxygen Species (ROS)-Based Nanomedicine. Chem. Rev. 2019;119:4881\u20134985. doi: 10.1021/acs.chemrev.8b00626.", "ArticleIdList": ["10.1021/acs.chemrev.8b00626", "30973011"]}, {"Citation": "Sakamuru S., Attene-Ramos M.S., Xia M. High-Throughput Screening Assays in Toxicology. Volume 1473. Humana; New York, NY, USA: 2016. Mitochondrial Membrane Potential Assay; pp. 17\u201322. Methods in Molecular Biology.", "ArticleIdList": ["10.1007/978-1-4939-6346-1_2", "PMC5375165", "27518619"]}, {"Citation": "Li Y., Li Y., Yao Y., Li H., Gao C., Sun C., Zhuang J. Potential of Cucurbitacin as an Anticancer Drug. Biomed. Pharmacother. 2023;168:115707. doi: 10.1016/j.biopha.2023.115707.", "ArticleIdList": ["10.1016/j.biopha.2023.115707", "37862969"]}, {"Citation": "Tung C.L., Jian Y.J., Chen J.C., Wang T.J., Chen W.C., Zheng H.Y., Chang P.Y., Liao K.S., Lin Y.W. Curcumin Downregulates P38 MAPK-Dependent X-Ray Repair Cross-Complement Group 1 (XRCC1) Expression to Enhance Cisplatin-Induced Cytotoxicity in Human Lung Cancer Cells. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2016;389:657\u2013666. doi: 10.1007/s00210-016-1235-5.", "ArticleIdList": ["10.1007/s00210-016-1235-5", "27026405"]}]}], "History": [{"Year": "2024", "Month": "4", "Day": "2"}, {"Year": "2024", "Month": "4", "Day": "30"}, {"Year": "2024", "Month": "5", "Day": "3"}, {"Year": "2024", "Month": "5", "Day": "25", "Hour": "10", "Minute": "55"}, {"Year": "2024", "Month": "5", "Day": "25", "Hour": "10", "Minute": "54"}, {"Year": "2024", "Month": "5", "Day": "25", "Hour": "1", "Minute": "25"}, {"Year": "2024", "Month": "5", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["38794168", "PMC11123751", "10.3390/ph17050598", "ph17050598"]}}]}